Stockscreener 앱 받기
36.34
0.03%
-0.010
시간 외 거래:
36.41
0.07
+0.19%
전일 마감가:
$36.35
열려 있는:
$35.95
하루 거래량:
702.33K
Relative Volume:
0.65
시가총액:
$2.70B
수익:
-
순이익/손실:
$-301.06M
주가수익비율:
-7.462
EPS:
-4.87
순현금흐름:
$-248.01M
1주 성능:
-2.76%
1개월 성능:
-12.39%
6개월 성능:
-3.53%
1년 성능:
-0.44%
1일 변동 폭
$35.39
$36.93
1주일 범위
$35.39
$37.60
52주 변동 폭
$28.21
$53.92
Springworks Therapeutics Inc Stock (SWTX) Company Profile
명칭
Springworks Therapeutics Inc
전화
203-883-9490
주소
100 WASHINGTON BOULEVARD, STAMFORD, CT
SWTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SWTX
Springworks Therapeutics Inc
|
36.34 | 2.70B | 0 | -301.06M | -248.01M | -4.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
399.35 | 102.84B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
702.59 | 77.21B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
619.96 | 37.07B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
236.01 | 30.44B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
112.58 | 26.99B | 3.30B | -501.07M | 1.03B | -2.1146 |
Springworks Therapeutics Inc Stock (SWTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-20 | 개시 | Evercore ISI | Outperform |
| 2024-02-05 | 개시 | Guggenheim | Buy |
| 2022-12-01 | 개시 | BofA Securities | Buy |
| 2021-01-19 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-29 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-05 | 개시 | Barclays | Overweight |
| 2020-03-19 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-03-04 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-01-21 | 재확인 | H.C. Wainwright | Buy |
| 2019-12-04 | 개시 | H.C. Wainwright | Buy |
| 2019-10-08 | 개시 | Cowen | Outperform |
| 2019-10-08 | 개시 | Goldman | Buy |
| 2019-10-08 | 개시 | JP Morgan | Overweight |
| 2019-10-08 | 개시 | Wedbush | Outperform |
모두보기
Springworks Therapeutics Inc 주식(SWTX)의 최신 뉴스
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives $69.50 Consensus Target Price from Brokerages - Defense World
How To Trade (SWTX) - Stock Traders Daily
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Principal Financial Group Inc. Has $29.43 Million Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Stifel Financial Corp Reduces Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
Low Grade Glioma Market Predicted to See Upsurge Through 2034, - openPR
Geode Capital Management LLC Has $53.53 Million Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Barclays PLC Raises Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Comprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight - GlobeNewswire Inc.
(SWTX) On The My Stocks Page - Stock Traders Daily
Comparing Titan Pharmaceuticals (NASDAQ:TTNP) & SpringWorks Therapeutics (NASDAQ:SWTX) - Defense World
Kuehn Law Encourages Investors of SpringWorks, Therapeutics Inc. to Contact Law Firm - GuruFocus.com
Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison's Top 2 Picks - Seeking Alpha
SpringWorks Therapeutics' SWOT analysis: stock potential amid clinical progress By Investing.com - Investing.com South Africa
SpringWorks Therapeutics' SWOT analysis: stock potential amid clinical progress - Investing.com India
Lord Abbett & CO. LLC Has $34.27 Million Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.20 Million Stock Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (SWTX) Up 14.5% Since Last Earnings Report: Can It Continue? - MSN
Main Management ETF Advisors LLC Buys Shares of 23,280 SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Charles Schwab Investment Management Inc. Raises Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
(SWTX) Trading Report - Stock Traders Daily
Soros Fund Management LLC Acquires 174,321 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Insider Sell Alert: Badreddin Edris Sells 20,000 Shares of Sprin - GuruFocus.com
Springworks Therapeutics COO sells $839,335 in stock By Investing.com - Investing.com UK
Erste Asset Management GmbH Takes Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Springworks Therapeutics CEO Islam Saqib sells $2 million in stock - Investing.com
Springworks Therapeutics CEO Islam Saqib sells $2 million in stock By Investing.com - Investing.com Nigeria
Saqib Islam Sells 49,000 Shares of SpringWorks Therapeutics Inc (SWTX) - GuruFocus.com
High Growth Tech Stocks to Watch in December 2024 - Simply Wall St
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Position Boosted by The Manufacturers Life Insurance Company - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by HighVista Strategies LLC - MarketBeat
Are Investors Eager To Sell Holdings In SpringWorks Therapeutics Inc (NASDAQ: SWTX)? - Stocks Register
Walleye Capital LLC Boosts Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Fmr LLC Boosts Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Intech Investment Management LLC Invests $676,000 in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Dynamic Technology Lab Private Ltd Buys Shares of 13,717 SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Ally Bridge Group NY LLC Invests $7.30 Million in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference - The Manila Times
SpringWorks Therapeutics to Present at Evercore ISI HealthCONx Conference | SWTX Stock News - StockTitan
Massachusetts Financial Services Co. MA Boosts Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
(SWTX) Investment Analysis - Stock Traders Daily
SpringWorks Therapeutics' SWOT analysis: stock shows promise amid challenges - Investing.com
Alpha DNA Investment Management LLC Makes New $411,000 Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
GSA Capital Partners LLP Makes New $209,000 Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
Eagle Asset Management Inc. Sells 54,366 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Trading 8.1% HigherShould You Buy? - MarketBeat
SpringWorks Therapeutics Inc. (SWTX): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts - Insider Monkey
Evercore ISI Begins Coverage on SpringWorks Therapeutics (NASDAQ:SWTX) - Defense World
SpringWorks started at outperform by Evercore ahead of FDA decision - MSN
Does SpringWorks Therapeutics (SWTX) Have the Potential to Rally 92.68% as Wall Street Analysts Expect? - MSN
Springworks Therapeutics Inc (SWTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.76%
1.06%
자본화:
|
볼륨(24시간):